My HPRA: Register

EXCEDRIN

250/250/65 Milligram Film Coated Tablet

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/122/001

Main Information

Trade NameEXCEDRIN
Active SubstancesACETYLSALICYLIC ACID
PARACETAMOL
CAFFEINE
Strength250/250/65 Milligram
Dosage FormFilm Coated Tablet
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/122/001

Group Information

ATC CodeN02BE51 Analgesics and antipyretics

Status

Authorised/WithdrawnTransfer Pending
Transfer Licence Issued16/12/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusMarketed
Promotion StatusPromotion to the general public
Conditions of LicenceRetail sale through pharmacies only in packs containing not more than 24 unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists. Packs containing more than 24 unit dosage forms are prescription only. Promotion to the general public for packs containing not more than 24 unit dosage forms. Promotion to healthcare professionals only for packs containing more than 24 unit dosage forms.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.